Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Aug;7(4):100548.
doi: 10.1016/j.esmoop.2022.100548. Epub 2022 Jul 16.

Vaccination for herpes zoster in patients with solid tumors: a position paper on the behalf of the Associazione Italiana di Oncologia Medica (AIOM)

P Pedrazzoli  1 , A Lasagna  2 , I Cassaniti  3 , A Ferrari  4 , F Bergami  3 , N Silvestris  5 , E Sapuppo  6 , M Di Maio  7 , S Cinieri  8 , F Baldanti  9
Affiliations
Review

Vaccination for herpes zoster in patients with solid tumors: a position paper on the behalf of the Associazione Italiana di Oncologia Medica (AIOM)

P Pedrazzoli et al. ESMO Open. 2022 Aug.

Abstract

Herpes zoster (HZ) is the infectious reactivation of the varicella-zoster virus. HZ is more frequent in immunocompromised subjects, including patients with cancer. HZ complications can even last for years with a consequent delay in treatment of the underlying malignancy and with an unfavorable impact on quality of life. Nowadays, HZ is a vaccine-preventable disease: the recent approval of adjuvanted glycoprotein E-based recombinant zoster vaccine has changed preventive perspectives in immunocompromised subjects. Recombinant zoster vaccine induced both strong humoral and cellular immune responses also in immunocompromised patients. The question is, therefore, to which categories of cancer patients we should recommend HZ vaccination. Based on a careful review of the available data present in the literature, including recommendations and expert opinions, we report the position of the Associazione Italiana di Oncologia Medica on HZ vaccination in adult patients with solid tumors, thus providing clinical practice advice in a field where clear-cut information is missing.

Keywords: RZV; cancer; herpes zoster; reactivation; vaccine.

PubMed Disclaimer

Conflict of interest statement

Disclosure The authors have declared no conflicts of interest.

References

    1. Galetta K.M., Gilden D. Zeroing in on zoster: a tale of many disorders produced by one virus. J Neurol Sci. 2015;358(1-2):38–45. - PMC - PubMed
    1. Rosamilia L.L. Herpes zoster presentation, management, and prevention: a modern case-based review. Am J Clin Dermatol. 2020;21(1):97–107. - PubMed
    1. Kawai K., Yawn B. Risk of herpes zoster in cancer patients and the promise of new vaccines. J Infect Dis. 2019;220(1):1–2. - PubMed
    1. Sim J.H., Cho H.S., Kim Y.D., et al. The association between herpes zoster and increased cancer risk: a nationwide population-based matched control study. Curr Oncol. 2021;28(4):2720–2730. - PMC - PubMed
    1. Gershon A.A., Breuer J., Cohen J.I., et al. Varicella zoster virus infection. Nat Rev Dis Primers. 2015;1 - PMC - PubMed

Substances